Sierra Leone’s members of parliament (MPs) are driving forward progress on immunization goals within their country. Yet many MPs who were instrumental in defending immunization budgets and pushing forward legislation were not re-elected this year.

For those of us in the neglected tropical disease (NTD) community, Washington, DC was an exciting place to be recently.

With final exams approaching throughout universities across the United States, the beginning of the semester – particularly the boring details of packing and moving and, oh, getting your updated vaccines – seems like a distant memory.  

Leaders in Fight Against Typhoid Express Hope in Light of New Vaccines

BANGKOK, THAILAND — November 5, 2013— The Coalition against Typhoid (CaT), an initiative of the Sabin Vaccine Institute, will convene scientists, researchers and biotech experts this week at the Vaccines for Enteric Diseases (VED) Conference to discuss how a highly anticipated conjugate typhoid vaccine could expedite global efforts to help prevent this disease. For the first time, children as young as six months of age can be protected against typhoid with a vaccine. Both adults and children will receive high levels of long lasting protection.

Michael Posner Joins Sabin Vaccine Institute’s Board of Trustees

WASHINGTON, DC – October 21, 2013 – The Sabin Vaccine Institute today announced the election to its Board of Trustees of Michael H. Posner, Professor of Business and Society at New York University’s Stern School of Business. For more than three decades, Mr. Posner has advanced the causes of inclusive global human rights, dignity, freedom and justice.

Dr. Albert B. Sabin is best known for developing the oral live virus polio vaccine, but his legacy extends far beyond this single groundbreaking medical advancement.

Pages

Subscribe to RSS - Vaccine Advocacy and Education